Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection and Pneumonia Risk in Chronic Obstructive Pulmonary Disease: A Network Analysis.

Fecha de publicación: 01/05/2020 Fecha Ahead of Print: 10/01/2020

Autores de IIS La Fe

Miguel Ángel Martínez García

Autor
Grace Jacqueline Oscullo Yépez

Autor

Participantes ajenos a IIS La Fe

Faner R
la Rosa-Carrillo D
Soler-Cataluña JJ
Ballester M
Agusti A

Grupos

Neumología

Leader

Miguel Ángel Martínez García

Abstract

Treatment of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroids (ICS) is controversial because it can reduce the risk of future exacerbations of the disease at the expense of increasing the risk of pneumonia.

Datos de la publicación

ISSN/ISSNe:: 1073-449X, 1535-4970
Tipo:: Article
Páginas:: 1078-1085
DOI:: 10.1164/rccm.201908-1550OC
PubMed:: 31922913
Factor de Impacto:: 6,272 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Martinez-Garcia MA:: La Fe University and Polytechnic Hospital, 16273, Pneumology Service, Valencia, Spain
Faner R:: Institut d'Investigacions Biomèdiques August Pi i Sunyer, 146245, Barcelona, Spain
Oscullo G:: Hospital Universitari i Politecnic La Fe, 16273, Valencia, Spain
la Rosa-Carrillo D:: Hospital Plato, 221694, Pneumology Unit, Barcelona, Spain
Soler-Cataluña JJ:: Hospital of Requena, 117016, Unidad de Neumología. Servicio Medicina Interna, Requena, Spain
Ballester M:: Hospital General De Requena, 117016, Requena, Spain
Agusti A:: Fundacio Clinic per a la Recerca Biomedica, 189152, Barcelona, Spain